STE - Company ID 0001757898
The table below shows STERIS plc's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|
| Revenue | $1.49B | $1.50B | $1.46B | $1.39B | $1.37B | $1.33B |
| Cost of revenue | $808.60M | $840.70M | $814.40M | $763.10M | $760.20M | $750.10M |
| Gross profit | $684.20M | $655.50M | $645.90M | $628.00M | $610.30M | $578.80M |
| R&D | $28.60M | $29.50M | $28.20M | $26.40M | $27.40M | $27.00M |
STERIS plc reported annual revenue of $5.94B for fiscal year 2026. That is up 8.7% from $5.46B in fiscal 2025. Over the 10 fiscal years shown, annual revenue grew from $2.61B (FY 2017) to $5.94B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $369.70M | $352.30M | $349.70M | $353.80M | $335.50M | $329.30M |
| Operating income | $285.80M | $273.20M | $265.80M | $246.00M | $245.30M | $219.70M |
| Income tax | $72.50M | $63.50M | $60.60M | $53.90M | $55.40M | $43.50M |
| Net income | $200.10M | $192.90M | $191.90M | $177.40M | $173.50M | $150.00M |
| EPS (diluted) | - | $1.96 | $1.94 | $1.79 | $1.75 | $1.51 |